Communiqués T2 Biosystems, Inc.

Actions

TTOO

US89853L3024

Equipement et technologie médicale avancés

Marché Fermé - OTC Markets 20:39:37 18/09/2026			Varia. 5j.	Varia. 1 janv.
0,000600 ^USD	+200,00%		-40,00%	-88,00%

03/02	T2 Biosystems annonce son intention de cesser ses activités	RE
03/02	T2 Biosystems, Inc. annonce son intention de finaliser la cessation de ses activités	CI

Communiqués

07/01/25	T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results	AQ
18/12/24	T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor	AQ
17/12/24	T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally	AQ
16/12/24	T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.	AQ
09/12/24	T2 Biosystems : Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct From Whole Blood Detection of Sepsis Causing Pathogens Form 8 K	PU
09/12/24	T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens	AQ
15/11/24	T2 Biosystems : Announces Third Quarter 2024 Financial Results Form 8 K	PU
14/11/24	T2 Biosystems: Q3 Earnings Snapshot	AQ
14/11/24	T2 Biosystems Announces Third Quarter 2024 Financial Results	AQ
05/11/24	T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024	AQ
16/10/24	T2 Biosystems : Trip Taylor, IR Form 8 K	PU
08/10/24	T2 Biosystems to Host Business Update Call on October 10, 2024	AQ
08/10/24	T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform	AQ
07/10/24	T2 Biosystems : Announces Preliminary Third Quarter 2024 Financial Results Form 8 K	PU
07/10/24	T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results	AQ
23/09/24	T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union	AQ
23/09/24	T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture	AQ
20/09/24	T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union	AQ
16/09/24	T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients	AQ
09/09/24	T2 Biosystems Provides Updates on its New Product Development Pipeline Progress	AQ
27/08/24	T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference	AQ
01/08/24	T2 Biosystems to Attend Upcoming Investor Conferences	AQ
29/07/24	T2 Biosystems: Q2 Earnings Snapshot	AQ
29/07/24	T2 Biosystems Announces Second Quarter 2024 Financial Results	AQ
29/07/24	T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor	AQ